+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Multiplexed Diagnostics Market by Product, Technology, Application, End User - Global Forecast to 2030- Product Image
Multiplexed Diagnostics Market by Product, Technology, Application, End User - Global Forecast to 2030- Product Image
Sale

Multiplexed Diagnostics Market by Product, Technology, Application, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 182 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968780
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Multiplexed diagnostics is redefining the landscape of clinical laboratory testing, empowering healthcare organizations to achieve greater diagnostic efficiency and precision through simultaneous detection of multiple biomarkers. Senior leaders evaluating this sector face an ecosystem shaped by technology convergence, evolving regulations, and shifting global manufacturing dynamics.

Market Snapshot: Multiplexed Diagnostics Market Size and Growth

The Multiplexed Diagnostics Market grew from USD 17.36 billion in 2024 to USD 20.42 billion in 2025. It is expected to continue growing at a CAGR of 16.78%, reaching USD 44.05 billion by 2030. Rapid expansion across advanced economies and emerging regions is propelled by demand for high-throughput testing capabilities and integration with next-generation sequencing, microarrays, and polymerase chain reaction systems. Organizations are increasingly adopting multiplexed platforms for applications spanning precision medicine, infectious disease surveillance, and oncology.

Scope & Segmentation

  • Product Types: Instruments (Immunoassay analyzers, Microarray devices, Next-generation sequencing instruments, PCR instruments), Kits and reagents (Immunoassay reagents, Microarray reagents, NGS reagents, PCR reagents), Software and services.
  • Technologies: Benchtop sequencers, High-throughput sequencers, Immunoassay platforms, Microarray systems.
  • Applications: Drug discovery and development, Genetic testing, Infectious diseases, Oncology.
  • End Users: Hospitals and clinics, Pharma and biopharma organizations (Biopharmaceutical companies, Pharmaceutical companies), Point-of-care testing centers, Reference laboratories.
  • Regions: Americas (United States—California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada; Mexico; Brazil; Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Companies: Danaher Corporation, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton, Dickinson and Company, QIAGEN N.V., Bio-Rad Laboratories, Inc., PerkinElmer, Inc., Luminex Corporation, Meso Scale Diagnostics, LLC.

Key Takeaways for Decision-Makers

  • Emerging multiplexed diagnostics technologies enable simultaneous analysis of proteins, nucleic acids, and small molecules, supporting advanced clinical and research applications.
  • The sector is undergoing rapid innovation in assay design, reagent chemistry, and automation, facilitating streamlined workflows and reduced sample turnaround times.
  • Regulatory adaptation and harmonization are expanding market opportunities across global healthcare settings, while new reimbursement models support broader clinical adoption.
  • Decentralized, point-of-care testing is fueling market growth, with compact platforms serving critical needs in diverse healthcare environments.
  • Strategic partnerships, portfolio expansions, and investments in software enhance vendor competitiveness and support integrated laboratory solutions.
  • Regional market trends vary: the United States leads with investment in innovation; European and Middle Eastern regions focus on protocol standardization and infrastructure; Asia-Pacific drives adoption through manufacturing and public health initiatives.

Assessing the 2025 Tariff Implications on US Diagnostics Market

Tariffs in the United States are directly impacting acquisition costs for laboratories, with import duties on critical multiplexed diagnostics instruments and reagent kits. Organizations are responding with supply chain adjustments, increased domestic production, or by shifting focus to software and service offerings less affected by tariffs. The complex, variable tariff environment challenges forecasting and procurement strategies, making agile operations and monitoring of policy developments vital for stakeholders.

Methodology & Data Sources

This research utilized comprehensive secondary source evaluations, including peer-reviewed journals and industry reports, then validated emerging trends with interviews from clinical, regulatory, and R&D leaders. Quantitative market analyses and expert workshops supported accuracy through data triangulation, ensuring impartial, robust insights relevant to senior decision-makers.

Why This Report Matters

  • Provides a clear landscape view of technological, regulatory, and regional factors disrupting the multiplexed diagnostics market.
  • Equips executives with actionable guidance for portfolio planning, procurement, and market expansion initiatives.
  • Enables informed responses to evolving global trade challenges and supports risk mitigation and investment strategies.

Conclusion

Senior executives navigating the multiplexed diagnostics sector require an integrated perspective on technology, regulation, and global market dynamics. This report offers the clarity needed to position organizations for sustained growth and innovation.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Multiplexed Diagnostics Market, by Product
8.1. Introduction
8.2. Instruments
8.2.1. Immunoassay Analyzers
8.2.2. Microarray Devices
8.2.3. Next Generation Sequencing Instruments
8.2.4. PCR Instruments
8.3. Kits and Reagents
8.3.1. Immunoassay Reagents
8.3.2. Microarray Reagents
8.3.3. NGS Reagents
8.3.4. PCR Reagents
8.4. Software and Services
9. Multiplexed Diagnostics Market, by Technology
9.1. Introduction
9.2. Benchtop Sequencers
9.3. High Throughput Sequencers
9.4. Immunoassay
9.5. Microarray
10. Multiplexed Diagnostics Market, by Application
10.1. Introduction
10.2. Drug Discovery and Development
10.3. Genetic Testing
10.4. Infectious Diseases
10.5. Oncology
11. Multiplexed Diagnostics Market, by End User
11.1. Introduction
11.2. Hospitals and Clinics
11.3. Pharma & Biopharma
11.3.1. Biopharmaceutical Companies
11.3.2. Pharmaceutical Companies
11.4. Point of Care Testing
11.5. Reference Laboratories
12. Americas Multiplexed Diagnostics Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Multiplexed Diagnostics Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Multiplexed Diagnostics Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Danaher Corporation
15.3.2. F. Hoffmann-La Roche Ltd
15.3.3. Thermo Fisher Scientific Inc.
15.3.4. Abbott Laboratories
15.3.5. Becton, Dickinson and Company
15.3.6. QIAGEN N.V.
15.3.7. Bio-Rad Laboratories, Inc.
15.3.8. PerkinElmer, Inc.
15.3.9. Luminex Corporation
15.3.10. Meso Scale Diagnostics, LLC
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. MULTIPLEXED DIAGNOSTICS MARKET MULTI-CURRENCY
FIGURE 2. MULTIPLEXED DIAGNOSTICS MARKET MULTI-LANGUAGE
FIGURE 3. MULTIPLEXED DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. MULTIPLEXED DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. MULTIPLEXED DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. MULTIPLEXED DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY MICROARRAY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PCR INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY MICROARRAY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY NGS REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PCR REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY BENCHTOP SEQUENCERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY HIGH THROUGHPUT SEQUENCERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 54. CANADA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. CANADA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 56. CANADA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 57. CANADA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 58. CANADA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. CANADA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. CANADA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2030 (USD MILLION)
TABLE 61. MEXICO MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. MEXICO MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 63. MEXICO MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 64. MEXICO MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 65. MEXICO MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. MEXICO MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 67. MEXICO MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 90. UNITED KINGDOM MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 91. UNITED KINGDOM MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 92. UNITED KINGDOM MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 93. UNITED KINGDOM MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 94. UNITED KINGDOM MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. UNITED KINGDOM MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. UNITED KINGDOM MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2030 (USD MILLION)
TABLE 97. GERMANY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 98. GERMANY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 99. GERMANY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 100. GERMANY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 101. GERMANY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. GERMANY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. GERMANY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2030 (USD MILLION)
TABLE 104. FRANCE MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 105. FRANCE MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 106. FRANCE MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 107. FRANCE MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 108. FRANCE MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. FRANCE MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. FRANCE MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2030 (USD MILLION)
TABLE 111. RUSSIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 112. RUSSIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 113. RUSSIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 114. RUSSIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 115. RUSSIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. RUSSIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2030 (USD MILLION)
TABLE 118. ITALY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. ITALY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 120. ITALY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 121. ITALY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 122. ITALY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. ITALY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. ITALY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2030 (USD MILLION)
TABLE 125. SPAIN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 126. SPAIN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 127. SPAIN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 128. SPAIN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 129. SPAIN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. SPAIN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. SPAIN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2030 (USD MILLION)
TABLE 132. UNITED ARAB EMIRATES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 133. UNITED ARAB EMIRATES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 134. UNITED ARAB EMIRATES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 135. UNITED ARAB EMIRATES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 136. UNITED ARAB EMIRATES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. UNITED ARAB EMIRATES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2030 (USD MILLION)
TABLE 139. SAUDI ARABIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 140. SAUDI ARABIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 141. SAUDI ARABIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 142. SAUDI ARABIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 143. SAUDI ARABIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. SAUDI ARABIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. SAUDI ARABIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2030 (USD MILLION)
TABLE 146. SOUTH AFRICA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 147. SOUTH AFRICA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 148. SOUTH AFRICA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 149. SOUTH AFRICA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 150. SOUTH AFRICA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. SOUTH AFRICA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. SOUTH AFRICA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2030 (USD MILLION)
TABLE 153. DENMARK MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 154. DENMARK MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 155. DENMARK MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 156. DENMARK MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 157. DENMARK MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. DENMARK MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 159. DENMARK MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2030 (USD MILLION)
TABLE 160. NETHERLANDS MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 161. NETHERLANDS MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 162. NETHERLANDS MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 163. NETHERLANDS MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2030 (USD MILLION)
TABLE 167. QATAR MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 168. QATAR MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 169. QATAR MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 170. QATAR MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 171. QATAR MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. QATAR MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. QATAR MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2030 (USD MILLION)
TABLE 174. FINLAND MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 175. FINLAND MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 176. FINLAND MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 177. FINLAND MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 178. FINLAND MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. FINLAND MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. FINLAND MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2030 (USD MILLION)
TABLE 181. SWEDEN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 182. SWEDEN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 183. SWEDEN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 184. SWEDEN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 185. SWEDEN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. SWEDEN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 187. SWEDEN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2030 (USD MILLION)
TABLE 188. NIGERIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 189. NIGERIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 190. NIGERIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 191. NIGERIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 192. NIGERIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. NIGERIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. NIGERIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2030 (USD MILLION)
TABLE 195. EGYPT MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 196. EGYPT MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 197. EGYPT MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 198. EGYPT MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 199. EGYPT MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. EGYPT MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. EGYPT MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2030 (USD MILLION)
TABLE 202. TURKEY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 203. TURKEY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 204. TURKEY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 205. TURKEY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 206. TURKEY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 207. TURKEY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 208. TURKEY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2030 (USD MILLION)
TABLE 209. ISRAEL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 210. ISRAEL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 211. ISRAEL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 212. ISRAEL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 213. ISRAEL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 214. ISRAEL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 215. ISRAEL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2030 (USD MILLION)
TABLE 216. NORWAY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 217. NORWAY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 218. NORWAY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 219. NORWAY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 220. NORWAY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. NORWAY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. NORWAY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2030 (USD MILLION)
TABLE 223. POLAND MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 224. POLAND MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 225. POLAND MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 226. POLAND MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 227. POLAND MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 228. POLAND MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. POLAND MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2030 (USD MILLION)
TABLE 230. SWITZERLAND MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 231. SWITZERLAND MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 232. SWITZERLAND MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 233. SWITZERLAND MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 234. SWITZERLAND MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. SWITZERLAND MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 236. SWITZERLAND MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2030 (USD MILLION)
TABLE 237. ASIA-PACIFIC MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 238. ASIA-PACIFIC MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 239. ASIA-PACIFIC MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 240. ASIA-PACIFIC MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 241. ASIA-PACIFIC MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 242. ASIA-PACIFIC MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 243. ASIA-PACIFIC MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2030 (USD MILLION)
TABLE 244. ASIA-PACIFIC MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 245. CHINA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 246. CHINA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 247. CHINA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 248. CHINA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 249. CHINA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. CHINA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 251. CHINA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2030 (USD MILLION)
TABLE 252. INDIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 253. INDIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 254. INDIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 255. INDIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 256. INDIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 257. INDIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 258. INDIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2030 (USD MILLION)
TABLE 259. JAPAN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 260. JAPAN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 261. JAPAN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 262. JAPAN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 263. JAPAN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. JAPAN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 265. JAPAN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2030 (USD MILLION)
TABLE 266. AUSTRALIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 267. AUSTRALIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 268. AUSTRALIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 269. AUSTRALIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 270. AUSTRALIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. AUSTRALIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 272. AUSTRALIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2030 (USD MILLION)
TABLE 273. SOUTH KOREA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 274. SOUTH KOREA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 275. SOUTH KOREA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 276. SOUTH KOREA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 277. SOUTH KOREA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 278. SOUTH KOREA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 279. SOUTH KOREA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2030 (USD MILLION)
TABLE 280. INDONESIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 281. INDONESIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 282. INDONESIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 283. INDONESIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 284. INDONESIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 285. INDONESIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 286. INDONESIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2030 (USD MILLION)
TABLE 287. THAILAND MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 288. THAILAND MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 289. THAILAND MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 290. THAILAND MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 291. THAILAND MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 292. THAILAND MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 293. THAILAND MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2030 (USD MILLION)
TABLE 294. PHILIPPINES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 295. PHILIPPINES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 296. PHILIPPINES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 297. PHILIPPINES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 298. PHILIPPINES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 299. PHILIPPINES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 300. PHILIPPINES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2030 (USD MILLION)
TABLE 301. MALAYSIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 302. MALAYSIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 303. MALAYSIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 304. MALAYSIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 305. MALAYSIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 306. MALAYSIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 307. MALAYSIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2030 (USD MILLION)
TABLE 308. SINGAPORE MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 309. SINGAPORE MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 310. SINGAPORE MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 311. SINGAPORE MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 312. SINGAPORE MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 313. SINGAPORE MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 314. SINGAPORE MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2030 (USD MILLION)
TABLE 315. VIETNAM MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 316. VIETNAM MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 317. VIETNAM MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 318. VIETNAM MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 319. VIETNAM MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 320. VIETNAM MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 321. VIETNAM MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2030 (USD MILLION)
TABLE 322. TAIWAN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 323. TAIWAN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 324. TAIWAN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 325. TAIWAN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 326. TAIWAN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 327. TAIWAN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 328. TAIWAN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2030 (USD MILLION)
TABLE 329. MULTIPLEXED DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
TABLE 330. MULTIPLEXED DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Multiplexed Diagnostics market report include:
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd
  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • QIAGEN N.V.
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer, Inc.
  • Luminex Corporation
  • Meso Scale Diagnostics, LLC

Table Information

Report AttributeDetails
No. of Pages182
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 20.42 Billion
Forecasted Market Value ( USD ) by 2030 $ 44.05 Billion
Compound Annual Growth Rate16.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Multiplexed Diagnostics - Global Strategic Business Report - Product Image

Multiplexed Diagnostics - Global Strategic Business Report

  • Report
  • 382 Pages
  • Global
From
High-Density Multiplexed Diagnostic Assays - Global Strategic Business Report - Product Image

High-Density Multiplexed Diagnostic Assays - Global Strategic Business Report

  • Report
  • 158 Pages
  • Global
From
Multiplexed Diagnostics Market 2025-2029 - Product Image

Multiplexed Diagnostics Market 2025-2029

  • Report
  • 235 Pages
  • Global
From
Syndromic Multiplex Diagnostics Market Size, Share & Trends Analysis Report By Type (Respiratory, Gastrointestinal, Central Nervous System), By End Use (Hospitals, Diagnostic Laboratories, Others), By Region And Segment Forecasts, 2025 - 2030 - Product Image

Syndromic Multiplex Diagnostics Market Size, Share & Trends Analysis Report By Type (Respiratory, Gastrointestinal, Central Nervous System), By End Use (Hospitals, Diagnostic Laboratories, Others), By Region And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Syndromic Multiplex Diagnostic Markets with COVID-19 Impacts. Strategies and Trends, Forecasts by Syndrome (Respiratory, Sepsis, GI Etc.), by Country, with Market Analysis, Executive Guides and Customization - Product Image

Syndromic Multiplex Diagnostic Markets with COVID-19 Impacts. Strategies and Trends, Forecasts by Syndrome (Respiratory, Sepsis, GI Etc.), by Country, with Market Analysis, Executive Guides and Customization

  • Report
  • 501 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.